TITLE

New deal from the World Trade Organisation

AUTHOR(S)
Pollock, Allyson M.; Price, David
PUB. DATE
September 2003
SOURCE
BMJ: British Medical Journal (International Edition);9/13/2003, Vol. 327 Issue 7415, p571
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Reports on the supposed resolution of the issue of giving poor countries access to essential medicines without breaching laws on intellectual property by the World Trade Organization (WTO). Past agreements; Allowance of drug companies to charge monopoly prices for essential drugs; Provisions for over-riding of patent protection for public health purposes; 2001 declaration stating the WTO's intention of finding an interpretation that squared the interest of pharmaceutical industries and poor countries; Description of the deal as a historical agreement by WTO director general Supachai Panitchpakdi; Grounds for scepticism; Basic problems with trade related aspects of intellectual property (TRIPS); Questions from the United Kingdom Commission on Intellectual Property Rights and Development Policy.
ACCESSION #
10844288

 

Related Articles

  • THIS WEEK.  // ICIS Chemical Business Americas;10/30/2006, Vol. 270 Issue 16, p46 

    The article reflects on two articles, published in previous issues of "ICIS Chemical Business Americas." According to the magazine's October 29, 1906 issue, the drug sector learned with considerable regret of the death of Charles Pfizer, the founder of the well-known house of Charles Pfizer &...

  • Bill to export generic drugs comes into force.  // HIV/AIDS Policy & Law Review;Aug2005, Vol. 10 Issue 2, p17 

    The article informs that the Jean Chrétien Pledge to Africa Act, the Canadian legislation aimed at allowing the export of lower-cost medicines to developing countries, came into force on May 14, 2005. The Act amends the Patent Act and the Food and Drugs Act to facilitate the export of...

  • Patent policy and public health in developing countries: lessons from Japan. Aoki, Reiko; Kubo, Kensuke; Yamane, Hiroko // Bulletin of the World Health Organization;May2006, Vol. 84 Issue 5, p417 

    The article discusses on the implications of the World Trade Organization's Trade-Related Aspects of Intellectual Property Rights Agreement on the public health sector in developing countries. Under the product patent law, local pharmaceutical companies are restricted to copy manufactured drugs...

  • The Sale of Antibiotics without Prescription in Pharmacies in Catalonia, Spain. Llor, Carl; Cots, Josep Maria // Clinical Infectious Diseases;5/15/2009, Vol. 48 Issue 10, p1345 

    Background. Current regulations in Spain state that antibiotics cannot be sold without a medical prescription. The objective of this study was to quantify the percentage of pharmacies selling antibiotics without an official medical prescription in Catalonia, Spain, by the simulation of 3...

  • Patent threat in emerging economies shifts to biotech. Jayaranam, Killugudi // Nature Biotechnology;May2008, Vol. 26 Issue 5, p481 

    This article reports on threats to pharmaceutical companies' intellectual property in emerging economies such as India, Brazil, and Thailand. Many of these countries have legislation allowing them to revoke patents if they are needed for urgent or emergency use and to invoke compulsory licenses...

  • THE "PUBLIC HEALTH" OF THE CONVENTIONAI. INTERNATIONAL PATENT REGIME & THE ETHICS OF "ETIIICALS:" ACCESS TO PATENTED MEDICINES. Khoury, Amir H. // Cardozo Arts & Entertainment Law Journal;2008, Vol. 26 Issue 1, p25 

    The article examines the Conventional International Patent Régime (CIPR) from the perspective of public health, particularly that of access to patented medicines (APM). It attempts to describe how CIPR regulates and impacts the APM issue. It seeks to explore whether the scope of patent rights...

  • Grudging waiver for the poorest. JISHNU, LATHA // Down to Earth;2015, Vol. 24 Issue 14, p54 

    The article reports that the U.S. President Barack Obama has opposed the demand of the least developed countries (LDCs) at the World Trade Organization (WTO) wherein the LDCs are given limited intellectual property obligations on medicines. It examines the indefinite exemption of LDCs from...

  • WTO DG.  // Presidents & Prime Ministers;Nov/Dec98, Vol. 7 Issue 6, p17 

    Reports that Australia will support the candidacy of Thai Deputy Prime Minister and Minister of Commerce Supachai Panitchpakdi as Director-General of the World Trade Organization (WTO). Reason behind Australia's decision; Importance of the position.

  • GPs left in the lurch when health makes headlines.  // Pulse;4/23/2005, Vol. 65 Issue 16, p22 

    The article reports that patients alarmed by the latest health scare are beleaguering General Practitioners (GP). GPs have had to become increasingly adept at crisis management over the course of 2004. But the systems in place for providing GPs with rapid, clear, sensible advice do not seem to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics